A computational study of the protein-ligand interactions in CDK2 inhibitors:: Using quantum mechanics/molecular mechanics interaction energy as a predictor of the biological activity

被引:45
作者
Alzate-Morales, Jans H. [1 ]
Contreras, Renato
Soriano, Alejandro
Tunon, Inaki
Silla, Estanislao
机构
[1] Univ Chile, Fac Ciencias, Dept Quim, Santiago, Chile
[2] Univ Valencia, Dept Quim Fis, Valencia, Spain
关键词
D O I
10.1529/biophysj.106.091512
中图分类号
Q6 [生物物理学];
学科分类号
071011 [生物物理学];
摘要
We report a combined quantum mechanics/ molecular mechanics (QM/MM) study to determine the protein-ligand interaction energy between CDK2 ( cyclin-dependent kinase 2) and five inhibitors with the N-2-substituted 6-cyclohexylmethoxypurine scaffold. The computational results in this work show that the QM/MM interaction energy is strongly correlated to the biological activity and can be used as a predictor, at least within a family of substrates. A detailed analysis of the protein-ligand structures obtained from molecular dynamics simulations shows specific interactions within the active site that, in some cases, have not been reported before to our knowledge. The computed interaction energy gauges the strength of protein-ligand interactions. Finally, energy decomposition and multiple regression analyses were performed to check the contribution of the electrostatic and van der Waals energies to the total interaction energy and to show the capabilities of the computational model to identify new potent inhibitors.
引用
收藏
页码:430 / 439
页数:10
相关论文
共 50 条
[1]
Ligand binding affinities from MD simulations [J].
Åqvist, J ;
Luzhkov, VB ;
Brandsdal, BO .
ACCOUNTS OF CHEMICAL RESEARCH, 2002, 35 (06) :358-365
[2]
Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles [J].
Arris, CE ;
Boyle, FT ;
Calvert, AH ;
Curtin, NJ ;
Endicott, JA ;
Garman, EF ;
Gibson, AE ;
Golding, BT ;
Grant, S ;
Griffin, RJ ;
Jewsbury, P ;
Johnson, LN ;
Lawrie, AM ;
Newell, DR ;
Noble, MEM ;
Sausville, EA ;
Schultz, R ;
Yu, W .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (15) :2797-2804
[3]
Protein flexibility and drug design: how to hit a moving target [J].
Carlson, HA .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (04) :447-452
[4]
Carlson HA, 2000, MOL PHARMACOL, V57, P213
[5]
Three-dimensional model of the cyclin-dependent kinase 1 (CDK1): Ab initio active site parameters for molecular dynamics studies of CDKs [J].
Cavalli, A ;
Dezi, C ;
Folkers, G ;
Scapozza, L ;
Recanatini, M .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 2001, 45 (04) :478-485
[6]
Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor [J].
Davies, TG ;
Bentley, J ;
Arris, CE ;
Boyle, FT ;
Curtin, NJ ;
Endicott, JA ;
Gibson, AE ;
Golding, BT ;
Griffin, RJ ;
Hardcastle, IR ;
Jewsbury, P ;
Johnson, LN ;
Mesguiche, V ;
Newell, DR ;
Noble, MEM ;
Tucker, JA ;
Wang, L ;
Whitfield, HJ .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (10) :745-749
[7]
Inhibitor binding to active and inactive CDK2: The crystal structure of CDK2-cyclin A/indirubin-5-sulphonate [J].
Davies, TG ;
Tunnah, P ;
Meijer, L ;
Marko, D ;
Eisenbrand, G ;
Endicott, JA ;
Noble, MEM .
STRUCTURE, 2001, 9 (05) :389-397
[8]
Inhibition of cyclin-dependent kinases by purine analogues - Crystal structure of human cdk2 complexed with roscovitine [J].
DeAzevedo, WF ;
Leclerc, S ;
Meijer, L ;
Havlicek, L ;
Strnad, M ;
Kim, SH .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (1-2) :518-526
[9]
THE DEVELOPMENT AND USE OF QUANTUM-MECHANICAL MOLECULAR-MODELS .76. AM1 - A NEW GENERAL-PURPOSE QUANTUM-MECHANICAL MOLECULAR-MODEL [J].
DEWAR, MJS ;
ZOEBISCH, EG ;
HEALY, EF ;
STEWART, JJP .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1985, 107 (13) :3902-3909
[10]
Field MJ, 2000, J COMPUT CHEM, V21, P1088, DOI 10.1002/1096-987X(200009)21:12<1088::AID-JCC5>3.0.CO